بنجلاديش - الإنجليزية - DGDA (Directorate General of Drug Administration)

unimed unihealth pharmaceuticals ltd. - disodium hydrogen phosphate dodecahydrate + sodium dihydrogen phosphate dihydrate - oral solution - 24 gm + 54.22 gm/100 ml

الإمارات العربية المتحدة - الإنجليزية - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

sodium chloride, disodium phosphate anhydrous, sodium dihydrogen phosphate dihydrate, sodium hyaluronate -

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - sodium dihydrogen phosphate anhydrous; sodium bicarbonate - suppository - 340mg ; 250mg

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 16.8 µg/ml - solution for injection - 16.8 mcg/ml - active: epoetin alfa 16.8 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 336 µg/ml - solution for injection - 336 mcg/ml - active: epoetin alfa 336 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 84 µg/ml - solution for injection - 84 mcg/ml - active: epoetin alfa 84 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

المملكة المتحدة - الإنجليزية - VMD (Veterinary Medicines Directorate)

b. braun vet care gmbh - glucose, magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium lactate -

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

alturix ltd - sodium dihydrogen phosphate anhydrous - effervescent tablet - 1.936gram

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

max health limited - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate phosphoric acid sodium hydroxide water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

b. braun singapore pte ltd - alanine; arginine; aspartic acid; calcium chloride dihydrate; glucose monohydrate; glutamic acid; glycine; histidine hydrochloride monohydrate; isoleucine; leucine; lysine hydrochloride; magnesium acetate tetrahydrate; methionine; omega-3-acid triglycerides; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; sodium chloride; sodium dihydrogen phosphate dihydrate; sodium hydroxide; soya-bean oil, refined; threonine; triglycerides, medium chain; tryptophan; valine; zinc acetate dihydrate - injection, emulsion - alanine 6.792g/1000ml; arginine 3.780g/1000ml; aspartic acid 2.100g/1000ml; calcium chloride dihydrate 0.623g/1000ml; glucose monohydrate 158.4g/1000ml; glutamic acid 4.908g/1000ml; glycine 2.312g/1000ml; histidine hydrochloride monohydrate 2.368g/1000ml; isoleucine 3.284g/1000ml; leucine 4.384g/1000ml; lysine hydrochloride 3.980g/1000ml; magnesium acetate tetrahydrate 0.910g/1000ml; methionine 2.736g/1000ml; omega-3-acid triglycerides 4.000g/1000ml; phenylalanine 4.916g/1000ml; potassium acetate 3.689g/1000ml; proline 4.760g/1000ml; serine 4.200g/1000ml; sodium acetate trihydrate 0.250g/1000ml; sodium chloride 0.378g/1000ml; sodium dihydrogen phosphate dihydrate 2.496g/1000ml; sodium hydroxide 1.171g/1000ml; soya-bean oil, refined 16.00g/1000ml; threonine 2.540g/1000ml; triglycerides, medium chain 20.00g/1000ml; tryptophan 0.800g/1000ml; valine 3.604g/1000ml; zinc acetate dihydrate 7.024mg/1000ml